RQM+ Acquires Jordi Labs

RQM+, the leading MedTech service provider with the world’s largest global team of regulatory and quality experts, and portfolio company of Linden Capital Partners, today announced the acquisition of Jordi Labs. With these new capabilities, RQM+ provides comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the entire product lifecycle for medical devices and diagnostics.

As the only MedTech service provider rooted in almost 40 years of regulatory strategy, RQM+ is proud to now offer proprietary testing services for extractables and leachables, which gives our customers the fastest path to regulatory approvals,” said CEO Margaret Keegan. “We are relentlessly focused on being the best at every service we provide to MedTech manufacturers. Jordi’s world-leading testing services will help us maintain our uncompromising quality standards at every stage as we grow into a one-stop-shop to expedite patient access to life-improving technologies.”

Through innovative new processes, Jordi Labs provides chemical characterization and complex product deformulation as well as contaminant and failure investigations to MedTech manufacturers. Their team of Ph.D. analytical chemists uses its proprietary, multi-detector approach to ensure that all extractables are accurately characterized to comply with global materials testing regulatory requirements. Jordi’s publications based on their multi-detector approach are frequently cited by both regulators and industry.

We are delighted to now be a part of the RQM+ solution that brings customers to market faster with our unmatched track record of rapid testing results that satisfy the stringent requirements of regulators globally,” said Mark Jordi, president of Jordi Labs. “Joining RQM+ will enable me to focus on what I love – developing groundbreaking technology that ensures patient safety by setting new standards for extractables and leachables testing.”

Kirkland and Ellis LLP served as legal advisor to Linden. Harris Williams represented Jordi Labs.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    RQM+. (2023, June 28). RQM+ Acquires Jordi Labs. News-Medical. Retrieved on April 23, 2024 from https://www.news-medical.net/news/20220909/RQM-Acquires-Jordi-Labs.aspx.

  • MLA

    RQM+. "RQM+ Acquires Jordi Labs". News-Medical. 23 April 2024. <https://www.news-medical.net/news/20220909/RQM-Acquires-Jordi-Labs.aspx>.

  • Chicago

    RQM+. "RQM+ Acquires Jordi Labs". News-Medical. https://www.news-medical.net/news/20220909/RQM-Acquires-Jordi-Labs.aspx. (accessed April 23, 2024).

  • Harvard

    RQM+. 2023. RQM+ Acquires Jordi Labs. News-Medical, viewed 23 April 2024, https://www.news-medical.net/news/20220909/RQM-Acquires-Jordi-Labs.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.